In type 1 and type 2 CRS, the renin-angiotensin-aldosterone system (RAAS) plays a pivotal role in the modulation of renal perfusion pressure and RAAS activation is associated with vasoconstriction mediated by enhanced release of endothelin [6]. This evidence concerns the gene REN and congenital rubella syndrome.